Table 5.
Summary of the model types used to assess the antinociceptive effect of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators.
| Model type | No. of studies | No. of nested comparisons |
|---|---|---|
| Inflammation | 434 | 467 |
| Nerve injury | 348 | 413 |
| Formalin | 223 | 235 |
| Chemotherapy | 112 | 128 |
| Diabetes | 63 | 74 |
| Cancer | 57 | 65 |
| Postoperative | 27 | 52 |
| Visceral inflammation | 20 | 31 |
| Chemical cauterization | 1 | 16 |
| Migraine | 9 | 13 |
| HIV | 4 | 11 |
| Capsaicin | 5 | 9 |
| Heat injury | 2 | 7 |
| Multiple sclerosis | 6 | 7 |
| Musculoskeletal | 2 | 4 |
| Antiretroviral | 1 | 3 |
| Burn injury | 1 | 3 |
| Mustard oil | 3 | 3 |
| Sickle cell disease | 2 | 2 |
| Mild traumatic brain injury | 1 | 1 |